newsfilter
← Latest News
GlobeNewswire·

Join BioVie's Exclusive Live Investor Webinar and Q&A Session on November 7th, 2024

CARSON CITY, Nev., Oct. 23, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and